Lobbying client

MDXHEALTH

molecular diagnostics company

The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 3 of its records are shown together here.

Filings
25
Filed by
3
Reported in-house
—
Reported by firms
$157,500

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2017 to 2022

Filings

25 filings, newest first.
Filing Filed by Amount
1st Quarter - Termination (No Activity)
1st Quarter 2022
CURA STRATEGIES — reported
4th Quarter - Report (No Activity)
4th Quarter 2021
CURA STRATEGIES — reported
3rd Quarter - Report
3rd Quarter 2021
CURA STRATEGIES — reported
2nd Quarter - Report
2nd Quarter 2021
CURA STRATEGIES — reported
1st Quarter - Report
1st Quarter 2021
CURA STRATEGIES — reported
4th Quarter - Report
4th Quarter 2020
CURA STRATEGIES — reported
3rd Quarter - Report
3rd Quarter 2020
CURA STRATEGIES $10,000 reported
2nd Quarter - Report
2nd Quarter 2020
CURA STRATEGIES — reported
1st Quarter - Report
1st Quarter 2020
CURA STRATEGIES $10,000 reported
4th Quarter - Report
4th Quarter 2019
CURA STRATEGIES $10,000 reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
CURA STRATEGIES 18 $117,500
MCDERMOTT+ LLC 2 $40,000
THE FEDERAL GROUP, INC. 2 —

Issues lobbied

How many report sections named each issue, counting the current version of each report.

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.